Viral disease prevention after hematopoietic cell transplantation
John A. Zaia(City Of Hope National Medical Center), Hans H. Hirsch(Department of Biomedicine Basel), Michael Boeckh(Fred Hutch Cancer Center), Hermann Einsele(Universitätsklinikum Würzburg), Per Ljungman(Karolinska University Hospital), Lindsey R. Baden(Brigham and Women's Hospital), Suparno Chakrabarti(University College Hospital), George B. McDonald(University of Washington)
Cited by 148
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
|Biology of Blood and Marrow Transplantation|2009|1.8k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k